Advertisement

Sex Cord-Stromal, Steroid Cell, and Other Ovarian Tumors with Endocrine, Paraendocrine, and Paraneoplastic Manifestations

Abstract

This category includes all ovarian neoplasms that contain granulosa cells, fibroblasts, theca cells (and their luteinized derivatives), Sertoli cells, Leydig cells, singly or in various combinations and in varying degrees of differentiation. Those who believe that all these cell types are derived from the “specialized stroma” of the genital ridge favor the term gonadal stromal tumors for these neoplasms [110]. Others, recognizing that many embryologists favor the participation of coelomic and mesonephric epithelium in the formation of sex cords, which are the proximal precursors of granulosa cells and Sertoli cells, favor the term sex cord-stromal tumors, and it is now the most widely accepted designation [144].

Keywords

Granulosa Cell Ovarian Tumor Leydig Cell Theca Cell Granulosa Cell Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgment

When the late Dr. Ancel Blaustein prepared the first edition of this book in the mid-1970s, he asked Dr. Robert E. Scully to contribute the chapter on ovarian sex cord-stromal tumors and it duly appeared in 1977. In the 1980s, I had the pleasure and privilege of reviewing numerous sex cord-stromal tumors of the ovary in Dr. Scully’s remarkable collection and a number of original publications with Dr. Scully and others came to pass. This resulted in Dr. Scully asking me if I would co-author the contribution on this topic for the third edition, expanded by the inclusion of consideration of steroid cell tumors and a variety of miscellaneous other neoplasms associated with various interesting clinical manifestations. This chapter appeared in the 1987 third edition. Dr. Scully, being retired, declined to participate in this most recent reedition of the chapter and although many of the words were initially written, or edited by him, given his customary awareness of the importance of ethics in medicine, he declined to have his name associated with a work which he did not actively participate in at this time. However, I would like to acknowledge my debt to Dr. Scully for the initial chapter, which laid the groundwork for everything to follow, the opportunity to learn from his cases, and most important of all, to be educated by him on the remarkable and fascinating microscopic spectrum encountered within the family of tumors reviewed in this chapter. Similar remarks pertain to  Chap. 18, Metastatics Tumors of the Ovary.

References

  1. 1.
    Aguirre P, Scully RE, Delellis RA (1986) Ovarian heterologous Sertoli–Leydig cell tumors with gastrointestinal-type epithelium. An immunohistochemical analysis. Arch Pathol Lab Med 110:528–533PubMedGoogle Scholar
  2. 2.
    Aguirre P, Thor AD, Scully RE (1989) Ovarian endometrioid carcinomas resembling sex cord-stromal tumors: an immunohistological study. Int J Gynecol Pathol 8:364–373PubMedCrossRefGoogle Scholar
  3. 3.
    Aguirre P, Thor AD, Scully RE (1989) Ovarian small cell carcinoma: histogenetic considerations based on immunohistochemical and other findings. Am J Clin Pathol 92:140–149PubMedGoogle Scholar
  4. 4.
    Ahmed E, Young RH, Scully RE (1999) Adult granulosa cell tumor of the ovary with foci of hepatic cell differentiation. A report of four cases and comparison with two cases of granulosa cell tumor with Leydig cells. Am J Surg Pathol 23:1089–1093PubMedCrossRefGoogle Scholar
  5. 5.
    Anderson MC, Rees DA (1975) Gynandroblastoma of the ovary. Br J Obstet Gynaecol 82:68–73PubMedCrossRefGoogle Scholar
  6. 6.
    Anderson PW, Macaulay L, Do YS et al (1989) Extrarenal renin-secreting tumors: Insights into hypertension and ovarian renin production. Medicine (Baltim) 68:257–268Google Scholar
  7. 7.
    Armstrong DT, Papkoff H (1976) Stimulation of aromatization by endogenous and exogenous androgens in ovaries of hypophysectomized rats in vivo by FSH. Endocrinology 99:1144–1151PubMedCrossRefGoogle Scholar
  8. 8.
    Ashton MA (1995) Strumal carcinoid of the ovary associated with hyperinsulinemic hypoglycemia and cutaneous melanosis. Histopathology (Oxf) 27:463–467CrossRefGoogle Scholar
  9. 9.
    Auranen A, Sundstrom JI, Ijas J, Grenman S (2007) Prognostic factors of ovarian granulosa cell tumor: a study of 35 patients and review of the literature. Int J Gynecol Cancer 17:1011–1018PubMedCrossRefGoogle Scholar
  10. 10.
    Axiotis CA, Lippes HA, Merino MJ, deLanerolle NC, Stewart AF, Kinder B (1987) Corticotroph cell pituitary adenoma within an ovarian teratoma. A new cause of Cushing’s syndrome. Am J Surg Pathol 11:218–224PubMedCrossRefGoogle Scholar
  11. 11.
    Baker PM, Oliva E (2004) Immunohistochemistry as a tool in the differential diagnosis of ovarian tumors: an update. Int J Gynecol Pathol 24:39–55Google Scholar
  12. 12.
    Banner EA, Dockerty MB (1945) Theca cell tumors of the ovary. A clinical and pathological study of twenty-three cases (including thirteen new cases) with a review. Surg Gynecol Obstet 81:234–242Google Scholar
  13. 13.
    Benfield GFA, Tapper-Jones L, Stout TV (1982) Androblastoma and raised serum alpha-fetoprotein with familial multinodular goitre. Case report. Br J Obstet Gynaecol 89:323–326PubMedCrossRefGoogle Scholar
  14. 14.
    Bjorkholm E (1980) Granulosa cell tumors: a comparison of survival in patients and matched controls. Am J Obstet Gynecol 138:329–331PubMedGoogle Scholar
  15. 15.
    Bjorkholm E, Pettersson F (1980) Granulosa-cell and theca-cell tumors. The clinical picture and long term outcome for the Radiumhemmet series. Acta Obstet Gynecol Scand 59:361–365PubMedCrossRefGoogle Scholar
  16. 16.
    Bjorkholm E, Silfversward C (1981) Prognostic factors in granulosa cell tumors. Gynecol Oncol 11:261–274PubMedCrossRefGoogle Scholar
  17. 17.
    Bjorkholm E, Silfversward C (1980) Theca-cell tumors. Clinical features and prognosis. Acta Radiol Oncol Radiat Phys Biol 19:241–244CrossRefGoogle Scholar
  18. 18.
    Bohm J, Roder-Weber M, Hofler H (1991) Bilateral stromal Leydig cell tumor of the ovary. Case report and literature review. Path Res Pract 187:348–352PubMedCrossRefGoogle Scholar
  19. 19.
    Boixeda D, Roman AL, Pascasio JM et al (1990) Zollinger-Ellison syndrome due to gastrin-secreting ovarian cystadenocarcinoma. Case report. Acta Chir Scand 156:409–410PubMedGoogle Scholar
  20. 20.
    Brown H, Lane M (1965) Cushing’s and malignant carcinoid syndromes from ovarian neoplasm. Arch Intern Med 115:490–494PubMedCrossRefGoogle Scholar
  21. 21.
    Brown WW, Shetty KR, Rosenfeld PS (1973) Hyperthyroidism due to struma ovarii: demonstration by radioiodine scan. Acta Endocrinol 73:266–272PubMedGoogle Scholar
  22. 22.
    Burton PBJ, Knight DE, Quirke P et al (1990) Parathyroid hormone related peptide in ovarian carcinoma. J Clin Pathol 43:784PubMedCrossRefGoogle Scholar
  23. 23.
    Callen JP (1986) Dermatomyositis and female malignancy. J Surg Oncol 32:121–124PubMedCrossRefGoogle Scholar
  24. 24.
    Cao QJ, Jones JG, Li M (2001) Expression of calretinin in human ovary, testis and ovarian sex cord-stromal tumors. Int J Gynecol Pathol 20:346–352PubMedCrossRefGoogle Scholar
  25. 25.
    Caron P, Roche H, Gorguet B, Martel P, Bennet A, Carton M (1990) Mammary ovarian metastases with stroma cell hyperplasia and postmenopausal virilization. Cancer (Phila) 66:1221–1224CrossRefGoogle Scholar
  26. 26.
    Cathro HP, Stoler MH (2005) The utility of calretinin, inhibin and WT1 immunohistochemistry staining in the differential diagnosis of ovarian tumors. Hum Pathol 36:195–201PubMedCrossRefGoogle Scholar
  27. 27.
    Chahud F, Young RH, Remulla JF et al (2001) Bilateral diffuse uveal melanocytic proliferation associated with extraocular cancers. Am J Surg Pathol 25:212–218PubMedCrossRefGoogle Scholar
  28. 28.
    Chalvardjian A, Scully RE (1973) Sclerosing stromal tumors of the ovary. Cancer (Phila) 31:664–670CrossRefGoogle Scholar
  29. 29.
    Christman JE, Ballon SC (1990) Ovarian fibrosarcoma associated with Maffucci’s syndrome. Gynecol Oncol 37:290–291PubMedCrossRefGoogle Scholar
  30. 30.
    Civantos F, Rywlin AM (1972) Carcinomas with trophoblastic differentiation and secretion of chroionic gonadotrophins. Cancer (Phila) 29:789–798CrossRefGoogle Scholar
  31. 31.
    Clement PB, Young RH, Hanna W, Scully RE (1994) Sclerosing peritonitis associated with luteinized thecomas of the ovary. A clinicopathological analysis of six cases. Am J Surg Pathol 18:1–13PubMedCrossRefGoogle Scholar
  32. 32.
    Cocconi G, Ceci G, Juvarra G et al (1985) Successful treatment of subacute cerebellar degeneration in ovarian carcinoma with plasmapheresis. A case report. Cancer (Phila) 56:2318–2320CrossRefGoogle Scholar
  33. 33.
    Cohen PR, Kohn SR, Kurzrock R (1991) Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome. Am J Med 90:606–613PubMedGoogle Scholar
  34. 34.
    Costa MJ, Ames PF, Walls J, Roth LM (1997) Inhibin immunohistochemistry applied to ovarian neoplasms: a novel, effective, diagnostic tool. Hum Pathol 281:247–254Google Scholar
  35. 35.
    Costa MJ, Morris R, DeRose PB, Cohen C (1993) Histologic and immunohistochemical evidence for considering ovarian myxoma as a variant of the thecoma-fibroma group of ovarian stromal tumors. Arch Pathol Lab Med 117:802–808PubMedGoogle Scholar
  36. 36.
    Costa MJ, Morris RJ, Wilson R, Judd R (1992) Utility of immunohistochemistry in distinguishing ovarian Sertoli-stromal cell tumors from carcinosarcomas. Hum Pathol 23:787–797PubMedCrossRefGoogle Scholar
  37. 37.
    Cramer SF, Bruns DE (1979) Amylase-producing ovarian neoplasm with pseudo-Meigs’ syndrome and elevated pleural amylase. Cancer (Phila) 44:1715–1721CrossRefGoogle Scholar
  38. 38.
    Crawford SM, Pyrah RD, Ismail SM (1994) Cushing’s syndrome associated with recurrent endometrioid adenocarcinoma of the ovary. J Clin Pathol 47:766–768PubMedCrossRefGoogle Scholar
  39. 39.
    Deavers MT, Malpica A, Liu J, Broaddus R, Silva E (2003) Ovarian sex cord-stromal tumors: An immunohistochenical study including a comparison of calretinin and inhibin. Mod Pathol 16:584–590PubMedCrossRefGoogle Scholar
  40. 40.
    Dickersin GR, Young RH, Scully RE (1995) Signet-ring stromal and related tumors of the ovary. Ultrastruct Pathol 19:401–419PubMedCrossRefGoogle Scholar
  41. 41.
    Dockerty MB, Masson JC (1944) Ovarian fibromas: a clinical and pathologic study of two hundred and eighty-three cases. Am J Obstet Gynecol 47:741–752Google Scholar
  42. 42.
    Dorrington JH, Moon YS, Armstrong DT (1975) Estradiol-17b biosynthesis in cultured granulosa cells from hypophysectomized immature rats: stimulation by FSH. Endocrinology 97:1328–1331PubMedCrossRefGoogle Scholar
  43. 43.
    Dunaif A, Hoffman AR, Scully RE et al (1985) Clinical, biochemical, and ovarian morphologic features in women with acanthosis nigricans and masculinization. Obstet Gynecol 66:545–552PubMedGoogle Scholar
  44. 44.
    Eichhorn JH, Bell DA, Young RH et al (1992) DNA content and proliferative activity in ovarian small cell carcinomas of the hypercalcemic type. Implications for diagnosis, prognosis and histogenesis. Am J Clin Pathol 98:579–586PubMedGoogle Scholar
  45. 45.
    Emerson RE, Wang M, Roth L, Zheng W, Abdul-Karim FW, Liu F, Ulbright TM, Eble JN, Cheng L (2007) Int J Gynecol Pathol 26:368–374PubMedCrossRefGoogle Scholar
  46. 46.
    Fathalla MF (1967) The occurrence of granulosa and theca tumors in clinically normal ovaries. A study of 25 cases. J Obstet Gynaecol Br Commonw 74:279–282CrossRefGoogle Scholar
  47. 47.
    Fathalla MF (1968) The role of the ovarian stroma in hormone production by ovarian tumors. J Obstet Gynaecol Br Commonw 75:78–83PubMedCrossRefGoogle Scholar
  48. 48.
    Fathizadeh A, Medenica MM, Soltani K et al (1982) Aggressive keratoacanthoma and internal malignant neoplasm. Arch Dermatol 118:112–114PubMedCrossRefGoogle Scholar
  49. 49.
    Ferry JA, Young RH, Engel G, Scully RE (1994) Oxyphilic Sertoli cell tumor of the ovary: a report of three cases, two in patients with the Peutz-Jeghers syndrome. Int J Gynecol Pathol 13:259–266PubMedCrossRefGoogle Scholar
  50. 50.
    Flemming P, Wellmann A, Maschek HJ et al (1995) Monoclonal antibodies against inhibin represents key markers of adult granulosa cell tumors of the ovary even in their metastases. Am J Surg Pathol 19:927–933PubMedCrossRefGoogle Scholar
  51. 51.
    Fox H, Agrawal K, Langley FA (1975) A clinicopathological study of 92 cases of granulosa cell tumor of the ovary with special reference to the factors influencing prognosis. Cancer (Phila) 35:231–241CrossRefGoogle Scholar
  52. 52.
    Fujino T, Watanabe T, Yamaguchi K et al (1992) The development of hypercalcemia in a patient with an ovarian tumor producing parathyroid hormone-related protein. Cancer (Phila) 70:2845–2850CrossRefGoogle Scholar
  53. 53.
    Gagnon S, Tetu B, Silva EG, McCaughey WTE (1989) Frequency of a-fetoprotein production by Sertoli-Leydig cell tumors of the ovary: an immunohistochemical study of eight cases. Mod Pathol 2:63–67PubMedGoogle Scholar
  54. 54.
    Garcia-Villaneuva M, Figuerola NB, del Arbol LR, Ortiz MJH (1990) Zollinger–Ellison syndrome due to a borderline mucinous cystadenoma of the ovary. Obstet Gynecol 75:549–551Google Scholar
  55. 55.
    Geist SH, Gaines JA (1938) Theca cell tumors. Am J Obstet Gynecol 35:39–51Google Scholar
  56. 56.
    Gorlin RJ (1987) Nevoid basal-cell carcinoma syndrome. Medicine (Baltim) 66:98–113Google Scholar
  57. 57.
    Guerrieri C, Frånlund B, Malmström H, Boeryd B (1998) Ovarian endometrioid carcinomas simulating sex cord-stromal tumors: a study using inhibin and cytokeratin 7. Int J Gynecol Pathol 17:266–271PubMedCrossRefGoogle Scholar
  58. 58.
    Gustafson ML, Lee MM, Scully RE et al (1992) Müllerian inhibiting substance as a marker for ovarian sex-cord tumor. N Engl J Med 326:466–471PubMedCrossRefGoogle Scholar
  59. 59.
    Hart WR, Kumar N, Crissman JD (1980) Ovarian neoplasms resembling sex cord tumors with annular tubules. Cancer (Phila) 45:2352–2363CrossRefGoogle Scholar
  60. 60.
    Hayes MC, Scully RE (1987) Ovarian steroid cell tumor (not otherwise specified): a clinicopathological analysis of 63 cases. Am J Surg Pathol 11:835–845PubMedCrossRefGoogle Scholar
  61. 61.
    Hayes MC, Scully RE (1987) Stromal luteoma of the ovary: a clinico-pathological analysis of 25 cases. Int J Gynecol Pathol 6:313–321PubMedCrossRefGoogle Scholar
  62. 62.
    Hoekman K, Tjandra Y, Papapoulos SE (1991) The role of 1, 25–dihydroxyvitamin D in the maintenance of hypercalcemia in a patient with an ovarian carcinoma producing parathyroid hormone-related protein. Cancer (Phila) 68:642–647CrossRefGoogle Scholar
  63. 63.
    Hoffman WH, Gala RR, Kovacs K, Subramanian MG (1987) Ectopic prolactin secretion from a gonadoblastoma. Cancer (Phila) 60:2690–2695CrossRefGoogle Scholar
  64. 64.
    Holguin T, Padilla RS, Ampuero F (1986) Ovarian adenocarcinoma presenting with the sign of Leser–Trelat. Gynecol Oncol 25:128–132PubMedCrossRefGoogle Scholar
  65. 65.
    Hoyt RE, Hamilton JF (1987) Ovarian cancer associated with the nephrotic syndrome. Obstet Gynecol 70:513–514PubMedGoogle Scholar
  66. 66.
    Hughesdon PE (1958) Thecal and allied reactions in epithelial ovarian tumours. J Obstet Gynaecol Br Commonw 65:702–709CrossRefGoogle Scholar
  67. 67.
    Hughesdon PE (1983) Lipid cell thecomas of the ovary. Histopathology (Oxf) 7:681–692CrossRefGoogle Scholar
  68. 68.
    Irving JA, Alkushi A, Young RH, Clement PB (2006) Cellular Fibromas of the ovary: a study of 75 cases including 40 mitotically active tumors emphasizing their distinction from fibrosarcoma. Am J Surg Pathol 30:928–938CrossRefGoogle Scholar
  69. 69.
    Irving JA, Young RH (2008) Granulosa cell tumors of the ovary with a pseudopapillary pattern: a study of 14 cases of an unusual morphologic variant emphasizing their distinction from transitional cell neoplasms and other papillary ovary tumors. Am J Surg Pathol 32:581–586PubMedCrossRefGoogle Scholar
  70. 70.
    Irving JA, Young RH (2008) Microcystic stromal tumor of the ovary. Report of 16 cases of a hitherto uncharacterized distinctive ovarian neoplasm. Am J Surg Pathol 33:367–375Google Scholar
  71. 71.
    Ismail SM, Walker SM (1990) Bilateral virilizing sclerosing stromal tumours of the ovary in a pregnant woman with Gorlin’s syndrome: implications for pathogenesis of ovarian stromal neoplasms. Histopathology (Oxf) 17:159–163CrossRefGoogle Scholar
  72. 72.
    Jackson B, Valentine R, Wagner G (1986) Primary aldosteronism due to a malignant ovarian tumour. Aust NZ J Med 16:69–71CrossRefGoogle Scholar
  73. 73.
    Kallenberg GA, Pesce CM, Norman B, Ratner RE, Silverberg SG (1990) Ectopic hyperprolactinemia resulting from an ovarian teratoma. JAMA 263:2472–2474PubMedCrossRefGoogle Scholar
  74. 74.
    Kommoss F, Oliva E, Bhan AK, Young RH, Scully RE (1998) Inhibin expression in ovarian tumors and tumor-like lesions: an immunohistochemical study. Mod Pathol 11:656–664PubMedGoogle Scholar
  75. 75.
    Konishi I, Fujii S, Ishikawa Y, Suzuki A, Okamura H, Mori T (1986) Ovarian fibroma with Leydig cell hyperplasia of the adjacent stroma: a light and electron microscopic study. Int J Gynecol Pathol 5:170–178PubMedGoogle Scholar
  76. 76.
    Korzets A, Nouriel H, Steiner Z et al (1986) Resistant hypertension associated with a renin-producing ovarian Sertoli cell tumor. Am J Clin Pathol 85:242–247PubMedGoogle Scholar
  77. 77.
    Kraemer BB, Silva EG, Sneige N (1984) Fibrosarcoma of the ovary. A new component in the nevoid basal-cell carcinoma syndrome. Am J Surg Pathol 8:231–236PubMedCrossRefGoogle Scholar
  78. 78.
    Kulkarni JN, Mistry RC, Kamat MR, Chinoy R, Lotlikar RG (1990) Autonomous aldosterone-secreting ovarian tumor. Gynecol Oncol 37:284–289PubMedCrossRefGoogle Scholar
  79. 79.
    Kurman RJ, Andrade D, Goebelsmann U, Taylor CR (1978) An immunohistochemical study of steroid localization in Sertoli–Leydig tumors of the ovary and testis. Cancer (Phila) 42:1772–1783CrossRefGoogle Scholar
  80. 80.
    Kurman RJ, Ganjei P, Nadjii M (1984) Contributions of immunocytochemistry to the diagnosis and study of ovarian neoplasms. Int J Gynecol Pathol 3:3–26PubMedCrossRefGoogle Scholar
  81. 81.
    Kurman RJ, Goebelsmann U, Taylor CR (1979) Steroid localization in granulosa–theca tumors of the ovary. Cancer (Phila) 43:2377–2384CrossRefGoogle Scholar
  82. 82.
    Lack EE, Perez-Atayde AR, Murthy ASK, Goldstein DP, Crigler JF, Vawter GF (1981) Granulosa theca cell tumors in premenarchal girls. A clinical and pathologic study of ten cases. Cancer (Phila) 48:1846–1854CrossRefGoogle Scholar
  83. 83.
    Margo CE, Pavan PR, Gendelman D, Gragoudas E (1987) Bilateral melanocytic uveal tumors associated with systemic non-ocular malignancy. Malignant melanomas or benign paraneoplastic syndrome? Retina 7:137–141PubMedCrossRefGoogle Scholar
  84. 84.
    Mason WP, Dalman J, Curtin MP, Posner JB (1997) Normalization of the tumor marker CA-125 after oophorectomy in a patient with paraneoplastic cerebellar degeneration without detectable cancer. Gynecol Oncol 65:1558–1563CrossRefGoogle Scholar
  85. 85.
    Matias-Guiu X, Pons C, Prat J (1998) Müllerian inhibiting substance, alpha-inhibin, and CD99 expression in sex cord stromal tumors and endometrioid ovarian carcinomas resembling sex cord-stromal tumors. Hum Pathol 29:840–845PubMedCrossRefGoogle Scholar
  86. 86.
    Matias-Guiu X, Prat J (1990) Ovarian tumors with functioning stroma. An immunohistochemical study of 100 cases with human chorionic gonadotropin monoclonal and polyclonal antibodies. Cancer (Phila) 65:2001–2005CrossRefGoogle Scholar
  87. 87.
    McCluggage WG (2008) Immunohistochemical markers as a diagnostic aid in ovarian pathology. Diagn Histopathol 14:335–351CrossRefGoogle Scholar
  88. 88.
    McCluggage WG, Maxwell P (1999) Adenocarcinomas of various sites may exhibit immunoreactivity with anti-inhibin antibodies. Histopathology 35:216–220PubMedCrossRefGoogle Scholar
  89. 89.
    McCluggage WG, Maxwell P (2001) Immunohistochemical staining for calretinin is useful in the diagnosis of ovarian sex cord-stromal tumours. Int J Gynecol Pathol 20:346–352CrossRefGoogle Scholar
  90. 90.
    McCluggage WG, Maxwell P, Sloan JM (1997) Immunohistochemical staining of ovarian granulosa cell tumors with monoclonal antibodies against inhibin. Hum Pathol 28:1034–1038PubMedCrossRefGoogle Scholar
  91. 91.
    McCluggage WG, McKenna M, McBride HA (2007) CD56 is a sensitive and diagnostically useful immunohistochemical marker of ovarian sex cord-stromal tumors. Int J Gynecol Pathol 26:322–327PubMedCrossRefGoogle Scholar
  92. 92.
    McCluggage WG, Oliva E, Connolly LE, Young RH (2004) An immunohistochemical analysis of ovarian small cell carcinoma of hypercalcemic type. Int J Gynecol Pathol 23:330–336PubMedCrossRefGoogle Scholar
  93. 93.
    McCluggage WG, Young RH (2005) Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors Semin Diagin Pathol 22:3–32CrossRefGoogle Scholar
  94. 94.
    McCluggage WG, Young RH (2007) Ovarian Sertoli-Leydig cell tumors with pseudoendometrioid tubules (pseudoendometrioid Sertoli-Leydig cell tumors). Am J Surg Pathol 31:592–596PubMedCrossRefGoogle Scholar
  95. 95.
    McKenna M, Kenny B, Dorman G, McCluggage WG (2005) Combined adult granulosa cell tumor and mucinous cystadenoma of the ovary: Granulosa cell tumor with heterologous mucinous elements. Int J Gynecol Pathol 24:224–227PubMedCrossRefGoogle Scholar
  96. 96.
    McMahon JT, Hart WR (1988) Ultrastructural analysis of small cell carcinomas of the ovary. Am J Clin Pathol 90:523–529PubMedGoogle Scholar
  97. 97.
    Medsger TA, Dixon JA, Garwood VF (1982) Palmar fasciitis and polyarthritis associated with ovarian carcinoma. Ann Intern Med 96:424–431PubMedGoogle Scholar
  98. 98.
    Meigs JV (1954) Fibroma of the ovary with ascites and hydrothorax. Meigs’ syndrome. Am J Obstet Gynecol 67:962–987PubMedGoogle Scholar
  99. 99.
    Mooney EE, Nogales FF, Bergeron C, Tavassoli FA (2002) Retiform Sertoli-Leydig cell tumours: clinical, morphological and immunohistochemical findings. Histopathology 41:110–117PubMedCrossRefGoogle Scholar
  100. 100.
    Mooney EE, Nogales FF, Tavassoli FA (1999) Hepatocytic differentiation in retiform Sertoli-Leydig cell tumors: distinguishing a heterologous element from Leydig cells. Hum Pathol 30:611–617PubMedCrossRefGoogle Scholar
  101. 101.
    Mooney EE, Vaidya KP, Tavassoli FA (2000) Ossifying well-differentiated Sertoli-Leydig cell tumor of the ovary. Ann Diagn Pathol 4:34–38PubMedCrossRefGoogle Scholar
  102. 102.
    Mordel N, Margalioth EJ, Harats N et al (1988) Concurrence of ovarian cancer and dermatomyositis. A report of two cases and literature review. J Reprod Med 33:649–655PubMedGoogle Scholar
  103. 103.
    Morgello S, Schwartz E, Horwith M et al (1988) Ectopic insulin production by a primary ovarian carcinoid. Cancer (Phila) 61:800–805CrossRefGoogle Scholar
  104. 104.
    Movahedi-Lankarani S, Kurman RJ (2002) Calretinin, a more sensitive but less specific marker than α-inhibin for ovarian sex cord-stromal neoplasms. An immunohistochemical study of 215 cases. Am J Surg Pathol 26:1477–1483PubMedCrossRefGoogle Scholar
  105. 105.
    Nakashima N, Young RH, Scully RE (1984) Androgenic granulosa cell tumors of the ovary. A clinicopathological analysis of seventeen cases and review of the literature. Arch Pathol Lab Med 108:786–791PubMedGoogle Scholar
  106. 106.
    Napoli VM, Wallach H (1976) Pancytopenia associated with a granulosa-cell tumor of the ovary. Report of a case. Am J Clin Pathol 65:344–350PubMedGoogle Scholar
  107. 107.
    Nguyen KQ, Hurst CG, Pierson DL et al (1983) Sweet’s syndrome and ovarian carcinoma. Cutis 32:152–154PubMedGoogle Scholar
  108. 108.
    Nichols J, Warren JC, Mantz FA (1962) ACTH-like excretion from carcinoma of the ovary. JAMA 182:713–718PubMedCrossRefGoogle Scholar
  109. 109.
    Nogales FF, Concha A, Plata C, Ruiz-Avila I (1993) Granulosa cell tumor of the ovary with diffuse true hepatic differentiation simulating stromal luteinization. Am J Surg Pathol 17:85–90PubMedCrossRefGoogle Scholar
  110. 110.
    Norris HJ, Taylor HB (1968) Prognosis of granulosa-theca tumors of the ovary. Cancer (Phila) 21:255–263CrossRefGoogle Scholar
  111. 111.
    Norris HJ, Taylor HB (1969) Virilization associated with cystic granulosa tumors. Obstet Gynecol 34:629–635PubMedGoogle Scholar
  112. 112.
    Norwood SH, Torma MJ, Fontanelle LJ (1981) Hyperamylasemia due to poorly differentiated adenosquamous carcinoma of the ovary. Arch Surg 116:225–226PubMedCrossRefGoogle Scholar
  113. 113.
    Nussbaum SR, Gas R, Arnold A (1990) Hypercalcemia and ectopic secretion of parathyroid hormone by an ovarian carcinoma with rearrangement of the gene for parathyroid hormone. N Engl J Med 323:1324–1328PubMedCrossRefGoogle Scholar
  114. 114.
    Oliva EA, Alvarez T, Young RH (2005) Sertoli cell tumors of the ovary. A clinicopathological and immunohistochemical study of 54 cases. Am J Surg Pathol 29:143–156PubMedCrossRefGoogle Scholar
  115. 115.
    Oliva E, Andrada E, Pezzica E, Prat J (1993) Ovarian carcinomas with choriocarcinomatous differentiation. Cancer (Phila) 72:2441–2446CrossRefGoogle Scholar
  116. 116.
    Oliva E, Garcia-Miralles N, Vu Q, Young RH (2007) CD10 expression in pure stromal and sex cord-stromal tumors of the ovary: an immunohistochemical analysis of 101 cases. Int J Gynecol Pathol 26:359–367PubMedCrossRefGoogle Scholar
  117. 117.
    O’Riordan T, Gaffney E, Tormey V, Daly P (1990) Hyperamylasemia associated with progression of a serous surface papillary carcinoma. Gynecol Oncol 36:432–434PubMedCrossRefGoogle Scholar
  118. 118.
    Palmer PE, Bogojavlensky S, Bhan AK, Scully RE (1990) Prolactinoma in wall of ovarian dermoid cyst with hyperprolactinemia. Obstet Gynecol 75:540–543PubMedGoogle Scholar
  119. 119.
    Paoletti M, Pridjian G, Okagaki T, Talerman A (1987) A stromal Leydig cell tumor of the ovary occurring in a pregnant 15-year-old girl. Ultrastructural findings. Cancer (Phila) 60:2806–2810CrossRefGoogle Scholar
  120. 120.
    Paraskevas M, Scully RE (1989) Hilus cell tumor of the ovary. A clinicopathological analysis of 12 Reinke crystal-positive and 9 crystal-negative cases. Int J Gynecol Pathol 8:299–310PubMedCrossRefGoogle Scholar
  121. 121.
    Parsons V, Rigby R (1958) Cushing’s syndrome associated with adenocarcinoma of the ovary. Lancet 2:992–994PubMedCrossRefGoogle Scholar
  122. 122.
    Payne D, Muss HB, Homesley HD, Jobson VW, Baird FG (1981) Autoimmune hemolytic anemia and ovarian dermoid cysts: case report and review of the literature. Cancer (Phila) 48:721–724CrossRefGoogle Scholar
  123. 123.
    Peterson K, Rosenblum MK, Kotanides H, Posner MP (1992) Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 42:1931–1937PubMedCrossRefGoogle Scholar
  124. 124.
    Pelkey TJ, Frierson HF, Mills SE, Stoler MH (1998) The diagnostic utility of inhibin staining in ovarian neoplasms. Int J Gynecol Pathol 17:97–105PubMedCrossRefGoogle Scholar
  125. 125.
    Phadke DM, Weisenberg E, Engel G, Rhone DP (1999) Malignant Sertoli cell tumor of the ovary metastatic of the lung mimicking neuroendocrine carcinoma: report of a case. Ann Diagn Pathol 3:213–219PubMedCrossRefGoogle Scholar
  126. 126.
    Prat J, Scully RE (1981) Cellular fibromas and fibrosarcomas of the ovary: a comparative clinicopathologic analysis of seventeen cases. Cancer (Phila) 47:2663–2670CrossRefGoogle Scholar
  127. 127.
    Prat J, Young RH, Scully RE (1982) Ovarian Sertoli-Leydig cell tumors with heterologous elements. (ii) cartilage and skeletal muscle: a clinicopathologic analysis of twelve cases. Cancer (Phila) 50:2465–2475CrossRefGoogle Scholar
  128. 128.
    Price A, Russell P, Elliott P, Bannatyne P (1990) Composite mucinous and granulosa-cell tumor of ovary: case report of a unique neoplasm. Int J Gynecol Pathol 9:372–378PubMedCrossRefGoogle Scholar
  129. 129.
    Ramzy I (1976) Signet-ring stromal tumor of ovary. Histochemical, light, and electron microscopic study. Cancer (Phila) 38:166–172CrossRefGoogle Scholar
  130. 130.
    Reddick RL, Walton LA (1982) Sertoli-Leydig cell tumor of the ovary with teratomatous differentiation. Cancer (Phila) 50:1171–1176CrossRefGoogle Scholar
  131. 131.
    Riopel MA, Perlman EJ, Seidman JD et al (1998) Inhibin and epithelial membrane antigen immunohistochemistry assist in the diagnosis of sex cord-stromal tumors and provide clues to the histogenesis of hypercalcemic small cell carcinomas. Int J Gynecol Pathol 17:46–53PubMedCrossRefGoogle Scholar
  132. 132.
    Rishi M, Howard LN, Bratthauer GL, Tavassoli FA (1997) Use of monoclonal antibodies against human inhibin as a marker for sex cord-stromal tumors of the ovary. Am J Surg Pathol 19:927–933Google Scholar
  133. 133.
    Roth LM, Anderson MC, Govan ADT, Langley FA, Gowing NFC, Woodcock AS (1981) Sertoli-Leydig cell tumors. A clinicopathologic study of 34 cases. Cancer (Phila) 48:187CrossRefGoogle Scholar
  134. 134.
    Roth LM, Slayton RE, Brady LW, Blesdsing JA, Johnson G (1985) Retiform differentiation in ovarian Sertoli–Leydig cell tumors. A clinicopathologic study of six cases from a gynecologic oncology study group. Cancer (Phila) 55:1093–1098CrossRefGoogle Scholar
  135. 135.
    Roth LM, Sternberg WH (1973) Ovarian stromal tumors containing Leydig cells. II. Pure Leydig cell tumor, non-hilar type. Cancer (Phila) 32:952–960CrossRefGoogle Scholar
  136. 136.
    Roth LM, Sternberg WH (1983) Partly luteinized theca cell tumor of the ovary. Cancer (Phila) 51:1697–1704CrossRefGoogle Scholar
  137. 137.
    Rutgers J, Scully RE (1986) Functioning ovarian tumors with peripheral steroid cell proliferation: a report of twenty-four cases. Int J Gynecol Pathol 5:319–337PubMedCrossRefGoogle Scholar
  138. 138.
    Sabin TD, Jednacz JA, Staats PN (2008) Case 26-2008: a 26-year-old woman with headache and behavioral changes. N Engl J Med 359:842–853PubMedCrossRefGoogle Scholar
  139. 139.
    Samanth KK, Black WC (1970) Benign ovarian stromal tumors associated with free peritoneal fluid. Am J Obstet Gynecol 107:538–545PubMedGoogle Scholar
  140. 140.
    Schofield PM, Kirsop BA, Reginald P, Harington M (1985) Ovarian carcinoma presenting as pyrexia of unknown origin. Postgrad Med J61:177–178Google Scholar
  141. 141.
    Scully RE (1953) An unusual ovarian tumor containing Leydig cells but associated with endometrial hyperplasia, in a postmenopausal woman. J Clin Endocrinol Metab 13:1254–1263PubMedCrossRefGoogle Scholar
  142. 142.
    Scully RE (1985) Immunohistochemistry of ovarian tumors. In: Russo J, Russo I (eds) Immunocytochemistry in tumor diagnosis. Martinus Nijhoff, Boston, MA, pp 293–320Google Scholar
  143. 143.
    Scully RE (1970) Sex cord tumor with annular tubules. A distinctive ovarian tumor of the Peutz–Jeghers syndrome. Cancer (Phila) 25:1107–1121CrossRefGoogle Scholar
  144. 144.
    Scully RE, Young RE, Clement PB (1998) Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. In: Atlas of tumor pathology, 3rd series, fasc 23. Armed Forces Institute of Pathology, Washington, DCGoogle Scholar
  145. 145.
    Scully RE, Aguirre P, DeLellis RA (1984) Argyrophilia, serotonin, and peptide hormones in the female genital tract and its tumors. Int J Gynecol Pathol 3:51–70PubMedCrossRefGoogle Scholar
  146. 146.
    Scully RE, Cohen RB (1964) Oxidative-enzyme activity in normal and pathologic human ovaries. Obstet Gynecol 24:667–681PubMedGoogle Scholar
  147. 147.
    Scully RE, Richardson GS (1961) Luteinization of the stroma of metastatic cancer involving the ovary and its endocrine significance. Cancer (Phila) 14:827–840CrossRefGoogle Scholar
  148. 148.
    Seidman JD (1996) Unclassified ovarian gonadal stromal tumors. A clinicopathologic study of 32 cases. Am J Surg Pathol 20:699–706PubMedCrossRefGoogle Scholar
  149. 149.
    Sens MA, Levenson TB, Metcalf JS (1982) A case of metastatic carcinoid arising in an ovarian teratoma. Case report with autopsy findings and review of the literature. Cancer (Phila) 49:2541–2546CrossRefGoogle Scholar
  150. 150.
    Shah SP, Kobel M, Senz J, Morin RD, Clarke BA et al (2009) Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Eng J Med 360:2719–2729Google Scholar
  151. 151.
    Simpson JL, Michael H, Roth LM (1998) Unclassified sex cord-stromal tumors of the ovary. A report of eight cases. Arch Pathol Lab Med 122:52–55PubMedGoogle Scholar
  152. 152.
    Sjostedt S, Wahlen T (1961) Prognosis of granulosa cell tumors. Acta Obstet Gynecol Scand 40:1–26Google Scholar
  153. 153.
    Solh HM, Azoury RS, Najjar SS (1983) Peutz–Jeghers syndrome associated with precocious puberty. J Pediatr 103:593–595PubMedCrossRefGoogle Scholar
  154. 154.
    Staats PN, McCluggage WG, Clement PB, Young RH (2008) Luteinized thecomas (thecomatosis) of the type typically associated with sclerosing peritonitis. Am J Surg Pathol 32:1273–1290PubMedCrossRefGoogle Scholar
  155. 155.
    Stenwig JT, Hazekamp JT, Beecham JB (1979) Granulosa cell tumors of the ovary. A clinicopathological study of 118 cases with long-term follow-up. Gynecol Oncol 7:136–152PubMedCrossRefGoogle Scholar
  156. 156.
    Sternberg WH (1949) The morphology, endocrine function, hyperplasia and tumors of the human ovarian hilus cells. Am J Pathol 25:493–511PubMedGoogle Scholar
  157. 157.
    Sternberg WH, Roth LM (1973) Ovarian stromal tumors containing Leydig cells. 1. Stromal-Leydig cell tumor and non-neoplastic transformation of ovarian stroma to Leydig cells. Cancer (Phila) 32:940–951CrossRefGoogle Scholar
  158. 158.
    Stewart CJR, Jeffers MD, Kennedy A (1997) Diagnostic value of inhibin immunoreactivity in ovarian gonadal stromal tumours and their histological mimics. Histopathology (Oxf) 31:67–74CrossRefGoogle Scholar
  159. 159.
    Stewart CJR, Nandini CL, Richmond JA (2000) Value of A103 (melan-A) immunostaining in the differential diagnosis of ovarian sex cord stromal tumours. J Clin Pathol 53:206–211PubMedCrossRefGoogle Scholar
  160. 160.
    Susil BJ, Sumithran E (1987) Sarcomatous change in granulosa cell tumor. Hum Pathol 18:397–399PubMedCrossRefGoogle Scholar
  161. 161.
    Talerman A (1987) Ovarian Sertoli-Leydig cell tumor (androblastoma) with retiform pattern: a clinicopathologic study. Cancer (Phila) 60:3056–3064CrossRefGoogle Scholar
  162. 162.
    Talerman A, Hughesdon PE, Anderson MC (1982) Diffuse nonlobular ovarian androblastoma usually associated with feminization. Int J Gynecol Pathol 1:155–171PubMedCrossRefGoogle Scholar
  163. 163.
    Taskin M, Barker B, Calanog A, Jormark S (1996) Syndrome of inappropriate antidiuresis in ovarian serous carcinoma with neuroendocrine differentiation. Gynecol Oncol 62:400–404PubMedCrossRefGoogle Scholar
  164. 164.
    Tavassoli FA, Norris HJ (1980) Sertoli tumors of the ovary. A clinicopathologic study of 28 cases with ultrastructural observations. Cancer (Phila) 46:2282–2297CrossRefGoogle Scholar
  165. 165.
    Taylor HB, Norris HJ (1967) Lipid cell tumors of the ovary. Cancer (Phila) 20:1953–1962CrossRefGoogle Scholar
  166. 166.
    Teilum G (1958) Classification of testicular and ovarian androblastoma and Sertoli cell tumors. Cancer (Phila) 11:769–782CrossRefGoogle Scholar
  167. 167.
    Todesco S, Terribile V, Borsatti A et al (1975) Primary aldosteronism due to a malignant ovarian tumor. J Clin Endocrinol Metab 41:809–819PubMedCrossRefGoogle Scholar
  168. 168.
    Tracy SL, Askin FB, Reddick RL, Jackson B, Kurman RJ (1985) Progesterone secreting Sertoli cell tumor of the ovary. Gynecol Oncol 22:85–96PubMedCrossRefGoogle Scholar
  169. 169.
    Tsunematsu R, Saito T, Iguchi H, Fukuda T, Tsukamoto N (2000) Hypercalcemia due to parathyroid hormone-related protein produced by primary ovarian clear cell adenocarcinoma: case report. Gynecol Oncol 76:218–222PubMedCrossRefGoogle Scholar
  170. 170.
    Tyler HR (1974) Paraneoplastic syndromes of nerve, muscle, and neuromuscular junction. Ann NY Acad Sci 230:348–357PubMedCrossRefGoogle Scholar
  171. 171.
    Ueda G, Nobuaki H, Hayakawa K et al (1972) Clinical histochemical and biochemical studies of an ovarian dysgerminoma with trophoblasts and Leydig cells. Am J Obstet Gynecol 114:748–754PubMedGoogle Scholar
  172. 172.
    Vang R, Vague S, Tavassoli F, Prat J (2003) Signet-ring stromal tumor of the ovary: clinicopathologic analysis and comparison with Krukenberg tumor. Int J Gynecol Pathol 23:45–51CrossRefGoogle Scholar
  173. 173.
    Verducci MA, Malkasian GD, Friedman SJ, Winkelmann RK (1984) Gynecologic carcinoma associated with dermatomyositis-polymyositis. Obstet Gynecol 64:695–698PubMedGoogle Scholar
  174. 174.
    von dem Borne AEGK, van Oers RHJ, Wiersinga WM et al (1990) Complete remission of autoimmune thrombocytopenia after extirpation of a benign adenofibroma of the ovary. Br J Rheumatol 74:119–120Google Scholar
  175. 175.
    Waxman M, Vuletin JC, Urcuyo R, Belling CG (1979) Ovarian low-grade stromal sarcoma with thecomatous features. A critical reappraisal of the so-called “malignant thecoma. Cancer (Phila) 44:2206–2217CrossRefGoogle Scholar
  176. 176.
    Young RH, Clement PB, Scully RE (1988) Calcified thecomas in young women. A report of four cases. Int J Gynecol Pathol 7:343–350PubMedCrossRefGoogle Scholar
  177. 177.
    Young RH, Dickersin GR, Scully RE (1983) A distinctive ovarian sex cord–stromal tumor causing sexual precocity in the Peutz–Jeghers syndrome. Am J Surg Pathol 7:233–243PubMedCrossRefGoogle Scholar
  178. 178.
    Young RH, Dickersin GR, Scully RE (1984) Juvenile granulosa cell tumor of the ovary. A clinicopathologic analysis of 125 cases. Am J Surg Pathol 8:575–596PubMedCrossRefGoogle Scholar
  179. 179.
    Young RH, Dudley AG, Scully RE (1984) Granulosa cell. Sertoli-Leydig cell and unclassified sex cord-stromal tumors associated with pregnancy. A clinicopathological analysis of thirty-six cases. Gynecol Oncol 18:181–205PubMedCrossRefGoogle Scholar
  180. 180.
    Young RH, Oliva E, Scully RE (1994) Lutenized adult granulosa cell tumors of the ovary: a report of four cases. Int J Gynecol Pathol 13:302–310PubMedCrossRefGoogle Scholar
  181. 181.
    Young RH, Oliva E, Scully RE (1994) Small cell carcinoma of the ovary, hypercalcemia type. A clinicopathological analysis of 150 cases. Am J Surg Pathol 18:1102–1116PubMedCrossRefGoogle Scholar
  182. 182.
    Young RH, Perez-Atayde AR, Scully RE (1984) Ovarian Sertoli-Leydig cell tumor with retiform and heterologous components. Report of a case with hepatocytic differentiation and elevated serum alpha-fetoprotein. Am J Surg Pathol 8:709–718PubMedCrossRefGoogle Scholar
  183. 183.
    Young RH, Prat J, Scully RE (1982) Ovarian Sertoli-Leydig cell tumors with heterologous elements. (i) Gastrointestinal epithelium and carcinoid: a clinicopathologic analysis of thirty-six cases. Cancer (Phila) 50:2448–2456CrossRefGoogle Scholar
  184. 184.
    Young RH, Scully RE (2001) Differential diagnosis of ovarian tumors based primarily on their patterns and cell types. Semin Diagn Pathol 18:161–235PubMedGoogle Scholar
  185. 185.
    Young RH, Scully RE (1983) Ovarian stromal tumors with minor sex cord elements: a report of seven cases. Int J Gynecol Pathol 2:227–234PubMedCrossRefGoogle Scholar
  186. 186.
    Young RH, Scully RE (1983) Ovarian sex cord-stromal tumors with bizarre nuclei. A clinicopathologic analysis of seventeen cases. Int J Gynecol Pathol 1:325–335PubMedCrossRefGoogle Scholar
  187. 187.
    Young RH, Scully RE (1983) Ovarian Sertoli-Leydig cell tumors with a retiform pattern: a problem in histopathologic diagnosis. A report of 25 cases. Am J Surg Pathol 7:755–771PubMedGoogle Scholar
  188. 188.
    Young RH, Scully RE (1984) Ovarian Sertoli cell tumors. A report of ten cases. Int J Gynecol Pathol 2:349–363PubMedCrossRefGoogle Scholar
  189. 189.
    Young RH, Scully RE (1987) Ovarian steroid cell tumors associated with Cushing’s syndrome. A report of three cases. Int J Gynecol Pathol 6:40–48PubMedCrossRefGoogle Scholar
  190. 190.
    Young RH, Scully RE (1984) Well-differentiated ovarian Sertoli–Leydig cell tumors. A clinicopathological analysis of 23 cases. Int J Gynecol Pathol 3:277–290PubMedCrossRefGoogle Scholar
  191. 191.
    Young RH, Scully RE (1985) Ovarian Sertoli-Leydig cell tumors. A clinicopathological analysis of 207 cases. Am J Surg Pathol 9:543–569PubMedCrossRefGoogle Scholar
  192. 192.
    Young RH, Welch WR, Dickersin GR, Scully RE (1982) Ovarian sex cord tumor with annular tubules: review of 74 cases including 27 with Peutz–Jeghers syndrome and 4 with adenoma malignum of the cervix. Cancer (Phila) 50:1384–1402CrossRefGoogle Scholar
  193. 193.
    Zaloudek C, Norris HJ (1982) Granulosa tumors of the ovary in children. A clinical and pathologic study of 32 cases. Am J Surg Pathol 6:503–512PubMedCrossRefGoogle Scholar
  194. 194.
    Zaloudek C, Norris HJ (1984) Sertoli-Leydig tumors of the ovary. A clinicopathologic study of 64 intermediate and poorly differentiated neoplasms. Am J Surg Pathol 8:405–418PubMedCrossRefGoogle Scholar
  195. 195.
    Zaloudek CJ, Tavassoli FA, Norris HJ (1981) Dysgerminoma with syncytiotrophoblastic giant cells. A histologically and clinically distinctive subtype of dysgerminoma. Am J Surg Pathol 5:361–367PubMedCrossRefGoogle Scholar
  196. 196.
    Zhang J, Young RH, Arseneau J, Scully RE (1982) Ovarian stromal tumors containing lutein or Leydig cells (luteinized thecomas and stromal Leydig cell tumors). A clinicopathological analysis of fifty cases. Int J Gynecol Pathol 1:270–285PubMedCrossRefGoogle Scholar
  197. 197.
    Zhao C, Bratthauer GL, Barner R, Vang R (2006) Immunohistochemical analysis of Sox9 in ovarian Sertoli cell tumors and other tumors in the differential diagnosis. Int J Gynecol Pathol 26:1–9CrossRefGoogle Scholar
  198. 198.
    Zhao C, Bratthauer GL, Barner R, Vang R (2007) Diagnostic Utility of WT1 immunostaining in ovarian Sertoli cell tumor. Am J Surg Pathol 31:1378–1386PubMedCrossRefGoogle Scholar
  199. 199.
    Zhao C, Bratthauer GL, Barner R, Vang R (2007) Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian Sertoli cell tumor from endometrioid tumors and carcinoid tumor: a study of 160 cases. Am J Surg Pathol 31:255–266PubMedCrossRefGoogle Scholar
  200. 200.
    Zhao C, Barner R, Vinh TN, McManus K, Dabbs D, Vang R (2008) SF-1 is a diagnostically useful immunohistochemical marker and comparable to other sex cord-stromal tumor markers for the differential diagnosis of ovarian Sertoli cell tumor. Int J Gynecol Pathol 27:507–514PubMedCrossRefGoogle Scholar
  201. 201.
    Zheng W, Sung CJ, Hanna I et al (1997) a and b subunits of inhibin/activin as sex cord-stromal differentiation markers. Int J Gynecol Pathol 16:263–271PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Anatomic PathologyJames Homer Wright Pathology Laboratories, Massachusetts General Hospital, Harvard Medical SchoolBostonUSA

Personalised recommendations